Andrew Hedin is a partner at Bessemer Venture Partners in the Boston office. See sector focus and contact routes.
Andrew Hedin is a partner at Bessemer Venture Partners in the Boston office, where he focuses on investments across the healthcare ecosystem, including new biotech therapeutics and healthcare software and services. Prior to joining Bessemer in 2015, he worked at F-Prime Capital, Fidelity’s healthcare-focused venture fund, investing in early-stage biotech, digital health, healthcare tech, and medtech startups. His investment thesis spans seed to Series B stages and beyond, covering sectors such as digital health, biotech, consumer health, and health IT, with a geographic focus on the intersection of technology and healthcare. Hedin’s typical check size ranges from $1 million to $250 million, though his specific lead or follow behavior is not publicly detailed. Notable portfolio companies include Kymera Therapeutics, for which he serves as a Board of Director. He holds an MBA with honors from The Wharton School in Health Care Management and Finance and a B.A. in Biological Basis of Behavior from the University of Pennsylvania. While Hedin serves on the steering committee of the New England Venture Network, there is no publicly available distinctive point of vi
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Boston when building a target list.
Investors like Andrew Hedin · Full investor directory · Investor access · Company funding database